Submitted by Anonymous (not verified) on 12 January 2026 - 16:18
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 4, Status: Authorised